Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-05 · accession 0001439222-24-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-07 | 2024-03-05+ | AGIO | Foster-Cheek Kaye I | Dir | S - Sale | $32.00 | -4,715 | 6,809 | -41% | -$150.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-03-05 | S | D | 300 | $32.21 | 11,224 | D | — | — | |
| 2 | Common | Common stock | 2024-03-06 | S | D | 4,415 | $31.99 | 6,809 | D | — | — | (F1) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $31.99 to $32.04. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |